Acorda Therapeutics (ACOR)
|
29.42
+0.42 (+1.45%)
|
|
|
|
ACOR additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ACOR Profile
•
Exchange
NASDAQ
•
Held by these Mutual Funds
•
Competitors
•
Executives
Dr. Ron Cohen M.D.
Founder
Chief Exec. Officer Pres and Director
Mr. David Lawrence M.B.A.
Chief Financial Officer and Principal Accounting Officer
Ms. Jane Wasman J.D.
Chief of Strategic Devel.
Gen. Counsel and Corp. Sec.
Ms. Lauren M. Sabella
Exec. VP of Commercial Devel.
Dr. Andrew R. Blight Ph.D.
Chief Scientific Officer
Founder
Chief Exec. Officer Pres and Director
Mr. David Lawrence M.B.A.
Chief Financial Officer and Principal Accounting Officer
Ms. Jane Wasman J.D.
Chief of Strategic Devel.
Gen. Counsel and Corp. Sec.
Ms. Lauren M. Sabella
Exec. VP of Commercial Devel.
Dr. Andrew R. Blight Ph.D.
Chief Scientific Officer
•
Employee Count
328
Special Offers
Competitors
ACOR earnings
Date
Actual
Expected
Prev Yr Qtr
10/31/2012
0.24
0.10
0.90
7/31/2012
0.11
0.12
0.07
5/3/2012
0.25
0.18
-0.02
